AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
5.58
-0.16 (-2.79%)
Aug 28, 2026, 4:00 PM EDT - Market closed
AN2 Therapeutics Market Cap
AN2 Therapeutics has a market cap or net worth of $210.57 million as of August 28, 2026. Its market cap has increased by 575.94% in one year.
Market Cap
210.57M
Enterprise Value
132.18M
1-Year Change
575.94%
Ranking
Category
Stock Price
$5.58
ChartMarket Cap Chart
Since the IPO on March 25, 2022, AN2 Therapeutics's market cap has decreased from $281.10M to $210.57M, a decrease of -25.09%. That is a compound annual growth rate of -6.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 210.57M | 574.07% |
| Dec 31, 2025 | 31.24M | -24.24% |
| Dec 31, 2024 | 41.23M | -93.23% |
| Dec 29, 2023 | 609.40M | 229.57% |
| Dec 30, 2022 | 184.91M | -34.22% |
| Mar 25, 2022 | 281.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Voyager Therapeutics | 218.13M |
| Coherus Oncology | 217.85M |
| Precision BioSciences | 214.74M |
| NovaBridge Biosciences | 213.44M |
| PepGen | 213.32M |
| Acumen Pharmaceuticals | 211.17M |
| Corbus Pharmaceuticals Holdings | 211.01M |
| Immunic | 210.12M |